Lee, Bo-Ching
Liu, Kao-Lang
Lin, Cheng-Li
Kao, Chia-Hung
Article History
Received: 20 December 2016
Revised: 5 May 2017
Accepted: 12 May 2017
First Online: 7 June 2017
Compliance with ethical standards
:
: The scientific guarantor of this publication is Prof. Chia-Hung Kao.
: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: This study is supported in part by the Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW106-TDU-B-212-113004), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST105-2325-B-039-003), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan, and Health and Welfare Surcharge of Tobacco Products, China Medical University Hospital Cancer Research Center of Excellence (MOHW105-TDU-B-212-134003, Taiwan). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.
: No complex statistical methods were necessary for this paper.
: This study was approved to fulfill the condition for exemption by the Institutional Review Board (IRB) of China Medical University (CMUH-104-REC2-115-CR1).
: Written informed consent was waived by the Institutional Review Board.
: • retrospective• observational study• performed in the national-wide population-based database